Melo, Micael N.Amaral, Ricardo G.Melo de Andrade, Lucas R.Severino, PatriciaBlanco-Llamero, CristinaAndrade, Luciana N.Souto, Eliana B.2026-01-272026-01-272025-07Melo, M N, Amaral, R G, Melo de Andrade, L R, Severino, P, Blanco-Llamero, C, Andrade, L N & Souto, E B 2025, 'An overview of randomized phase III clinical trials of cancer nanomedicines', Cancer Pathogenesis and Therapy, vol. 3, no. 4, pp. 322-336. https://doi.org/10.1016/j.cpt.2024.10.0012097-2563unpaywall: 10.1016/j.cpt.2024.10.001PubMedCentral: PMC12277848https://hdl.handle.net/10641/7501Publisher Copyright: © 2024 The Author(s)15815008enghttp://creativecommons.org/licenses/by-nc-nd/4.0/Antineoplastic drugsChemotherapyClinical trialsDrug delivery systemsNanomedicinePersonalized medicineCancer ResearchPathology and Forensic MedicineHistologyOncologySDG 3 - Good Health and Well-beingJournal ArticleReviewYesyesreview articleopen access10.1016/j.cpt.2024.10.001https://www.scopus.com/pages/publications/85208241993https://www.scopus.com/pages/publications/85208241993#tab=citedBy